Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
In 2022, CureVac sued rival BioNTech for patent infringement, claiming some of that company’s success in COVID-19 was based on CureVac’s intellectual property. Litigation between the two ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...
However, a lawsuit filed in February 2023 claims that the products not only don’t live up to their hype—they are actively dangerous. Here’s what you need to know about the Olaplex lawsuit.
Shares of biopharmaceutical company CureVac touched a new low on Wednesday following news the company, together with GSK, ended a pandemic agreement with Germany and will implement an ...
The four voters, in conjunction with Disability Rights Wisconsin and the liberal-leaning League of Women Voters, filed a lawsuit in Dane County Circuit Court Tuesday that argues their right to a ...
CureVac is asserting its intellectual property rights in litigation against Pfizer/BioNTech in Germany, the U.S. and the UK. In the U.S., a magistrate judge recently granted a motion by Acuitas ...
Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the ...